Investors

Financials

v3.25.4
Condensed Consolidated Balance Sheets
Dec. 31, 2025
USD ($)
Jun. 30, 2025
USD ($)
CURRENT ASSETS:    
Cash $ 561,237 $ 12,088
GST tax receivable 16,994 5,302
Prepaid expenses - current portion 7,127,293 8,334,046
Other current assets 1,400 1,380
TOTAL CURRENT ASSETS 7,706,924 8,352,816
Deferred offering costs 291,773
Prepaid expenses - long-term portion 7,347,310 10,925,835
Security deposit - related party 2,000 1,971
Operating lease right-of-use assets, net - related party 50,901 59,413
Property and equipment, net 4,397
TOTAL ASSETS 15,111,532 19,631,808
CURRENT LIABILITIES:    
Accounts payable 957,483 1,249,596
Accrued expenses and other payables 860,463 1,486,550
Accrued interest 168,152 190,795
Notes payable, net of discount 543,312
Convertible notes, net of discounts and including put premiums 55,000 537,921
Operating lease liability - related party, current portion 21,604 17,664
Warrant liability 288,635
Embedded conversion option liabilities 32,128 403,892
Employee benefit liability 703,190 667,901
TOTAL CURRENT LIABILITIES 3,624,018 5,578,240
NON-CURRENT LIABILITIES:    
Loan payable - long-term - related party, net of discount 105,627
Operating lease liability - long-term portion - related party 35,249 41,749
TOTAL NON-CURRENT LIABILITIES 35,249 147,376
TOTAL LIABILITIES 3,659,267 5,725,616
Temporary Equity – Convertible Preferred Stock Series C - $0.01 par value, $10,000 stated value, 9,900 shares designated and authorized, 100 (liquidation value of $1,000,000) and none issued and outstanding at December 31, 2025 and June 30, 2025, respectively 1,000,000
Commitments and Contingencies (See Note 9)
STOCKHOLDERS’ EQUITY:    
Common stock, $0.001 par value; 10,000,000,000 shares authorized; 13,449,688 and 11,611,782 shares issued and outstanding as of December 31, 2025 and June 30, 2025, respectively 13,450 11,612
Common stock issuable (7,750 and 7,750 shares as of December 31, 2025 and June 30, 2025, respectively) 8 8
Additional paid-in capital 143,640,067 138,243,652
Accumulated other comprehensive income 1,328,115 1,318,917
Accumulated deficit (134,482,898) (125,621,520)
Treasury stock ($0.001 share) (46,477) (46,477)
TOTAL STOCKHOLDERS’ EQUITY 10,452,265 13,906,192
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY 15,111,532 19,631,808
Series A Preferred Stock [Member]    
STOCKHOLDERS’ EQUITY:    
Preferred stock, value
Series B Preferred Stock [Member]    
STOCKHOLDERS’ EQUITY:    
Preferred stock, value
Nonrelated Party [Member]    
CURRENT LIABILITIES:    
Loans payable 65,280 65,280
Related Party [Member]    
CURRENT ASSETS:    
Operating lease right-of-use assets, net - related party 50,901 59,413
CURRENT LIABILITIES:    
Loans payable 472,083 415,329
Operating lease liability - related party, current portion 21,604 17,664
NON-CURRENT LIABILITIES:    
Loan payable - long-term - related party, net of discount 0 105,627
Operating lease liability - long-term portion - related party $ 35,249 $ 41,749

Source

v3.25.4
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
REVENUE        
Revenue
OPERATING EXPENSES        
Administration expenses 3,628,173 153,593 8,226,747 374,352
Occupancy expenses - related party 6,600 5,401 21,389 13,718
Research and development 19,961 54,388 80,162 116,102
TOTAL OPERATING EXPENSES 3,654,734 213,382 8,328,298 504,172
LOSS FROM OPERATIONS (3,654,734) (213,382) (8,328,298) (504,172)
OTHER INCOME (EXPENSE)        
Interest expense (58,955) (118,943) (364,604) (205,173)
Interest income 37 56 1
Derivative expense (8,559) (35,741)
Change in fair value of derivative liabilities 87,728 13,581 68,022 66,368
Change in fair value of warrant liability 593,710 593,710
Other expense (54,000) (54,000)
Gain (loss) on extinguishment of debt, net 14,317 (18,759) 210,178 (30,078)
Foreign currency transaction gain (loss) (19,497) (84,121) (54,196) (75,698)
TOTAL OTHER INCOME (EXPENSE), NET 563,340 (216,801) 399,166 (280,321)
LOSS BEFORE TAXES (3,091,394) (430,183) (7,929,132) (784,493)
Tax benefit
NET LOSS (3,091,394) (430,183) (7,929,132) (784,493)
Deemed Dividend (932,246) (932,246)
NET LOSS $ (4,023,640) $ (430,183) $ (8,861,378) $ (784,493)
BASIC NET LOSS PER SHARE $ (0.30) $ (32.23) $ (0.69) $ (67.65)
DILUTED NET LOSS PER SHARE $ (0.30) $ (32.23) $ (0.69) $ (67.65)
BASIC WEIGHTED AVERAGE SHARES OUTSTANDING 13,360,358 13,347 12,848,520 11,597
DILUTED WEIGHTED AVERAGE SHARES OUTSTANDING 13,360,358 13,347 12,848,520 11,597
OTHER COMPREHENSIVE INCOME (LOSS)        
Unrealized foreign currency translation gain (loss) $ (7,846) $ 321,230 $ 9,198 $ 222,287
TOTAL OTHER COMPREHENSIVE INCOME (LOSS) (7,846) 321,230 9,198 222,287
TOTAL COMPREHENSIVE LOSS $ (4,031,486) $ (108,953) $ (8,852,180) $ (562,206)

Source

v3.25.4
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Dec. 31, 2025
Sep. 30, 2025
Dec. 31, 2024
Sep. 30, 2024
Dec. 31, 2025
Dec. 31, 2024
Jun. 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES:              
Net loss $ (3,091,394) $ (4,837,738) $ (430,183) $ (354,310) $ (7,929,132) $ (784,493)  
Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities:              
Issuance of common stock for services         733,748 15,000  
Amortization of prepaid stock based expenses         5,496,367  
Foreign currency transaction loss (gain)         54,196 75,698  
Depreciation expense 229     354  
Amortization of debt discounts         186,777 133,644  
Amortization of right-of-use assets         9,380 9,866  
Change in fair value of derivative liabilities (87,728)   (13,581)   (68,022) (66,368)  
Change in fair value of warrant liability (593,710)     (593,710)  
Derivative expense   8,559   35,741  
Loss (gain) on extinguishment of debt, net (14,317)   18,759   (210,178) 30,078  
Non-cash interest expense         5,843 4,582  
Accretion of put premium         37,450  
Changes in Assets and Liabilities:              
GST receivable         (11,615) 752  
Prepaid expenses         (28,590) (80)  
Other current assets          
Accounts payable         (310,368) 102,374  
Employee benefit liability         25,531 20,666  
Accrued expenses and other payables         (351,663) 166,993  
Accrued interest         18,853 49,350  
Operating lease liability         (3,428) (10,589)  
NET CASH USED IN OPERATING ACTIVITIES         (2,938,207) (216,786)  
CASH FLOWS FROM INVESTING ACTIVITIES:              
Purchase of equipment         (4,758)  
NET CASH USED IN INVESTING ACTIVITIES         (4,758)  
CASH FLOWS FROM FINANCING ACTIVITIES:              
Proceeds from convertible promissory notes, net of original issue discounts and issue costs         100,000 80,000  
Proceeds from issuance of convertible Series C Preferred stock, net of issuance cost         950,099  
Repayment of convertible notes         (203,350)  
Repayment of notes         (671,777) (98,400)  
Repayment of loans payable - related party         (150,808)  
Proceeds from the sale of common stock, net of offering costs         3,314,458  
Proceeds from note payable         75,000 35,000  
Proceeds from loans payable - related parties         78,249 278,915  
Deferred offering costs         (25,000)  
NET CASH PROVIDED BY FINANCING ACTIVITIES         3,491,871 270,515  
Effect of exchange rate changes on cash         243 (60,181)  
NET INCREASE (DECREASE) IN CASH         549,149 (6,452)  
CASH AT BEGINNING OF PERIOD   $ 12,088   $ 21,085 12,088 21,085 $ 21,085
CASH AT END OF PERIOD $ 561,237   $ 14,633   561,237 14,633 $ 12,088
Cash paid during the period:              
Interest         115,684 17,599  
Income Tax          
Supplemental Disclosure of Non-Cash Investing and Financing Activities              
Reduction of put premium related to conversions of convertible notes         114,399 9,336  
Conversion of convertible notes and accrued interest to common stock         416,291 71,836  
Defferred offering cost charged to additional paid in capital upon closing of offering         281,773  
Debt discounts related to derivative liability         80,000  
Deemed dividend related to Series C Preferred Stock         $ 932,246  

Source

Sign up for email alerts

Be the first to receive breaking news

Sign up today